| Period Ending | Mar 29, 2013 | Dec 30, 2012 | Sep 28, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
3,947,100
|
3,719,400
|
3,538,600
|
3,665,000
| | Cost of Revenue | 3,634,700 | 3,417,600 | 3,247,300 | 3,350,400 | | |
Gross Profit
|
312,400
|
301,800
|
291,300
|
314,600
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 129,600 | 132,500 | 113,400 | 117,300 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 8,600 | 10,500 | 8,300 | 7,300 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
174,200
|
158,800
|
169,600
|
190,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (10,700) | 5,600 | (1,500) | (10,200) |
|
Earnings Before Interest And Taxes | 163,500 | 164,400 | 168,100 | 179,800 |
|
Interest Expense | 16,700 | 9,700 | 13,700 | 14,000 |
|
Income Before Tax | 146,800 | 154,700 | 154,400 | 165,800 |
|
Income Tax Expense | 37,900 | (738,400) | 29,300 | 31,800 |
|
Minority Interest | (8,400) | (8,200) | (6,700) | (9,200) |
|
|
|
Net Income From Continuing Ops | 108,500 | 881,900 | 121,400 | 145,400 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
108,500
|
881,900
|
121,400
|
145,400
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
108,500
|
881,900
|
121,400
|
145,400
|
|
0.73%